A Systematic Review: Fecal Bacterial Profile in Patients with Irritable Bowel Syndrome Analyzed with the GA-Map Dysbiosis Test Based on the 16S rRNA Gene of Bacterial Species or Groups
Open Access
- 1 April 2024
- journal article
- review article
- Published by Taylor & Francis in Clinical and Experimental Gastroenterology
- Vol. ume 17, 109-120
Abstract
Purpose: The diagnosis of irritable bowel syndrome (IBS) is based on symptom-based criteria due to lack of reliable disease-specific biomarkers. Gut microbiota is perturbed in IBS and when comparing different methods used to analyze gut microbiota, the results might be obscured. Therefore, in this systematic review we aimed to investigate the profile of fecal bacterial markers and dysbiosis index (DI) in patients with IBS and IBS subgroups compared to healthy controls (HCs) conducted by the same method (GA-map Dysbiosis Test based on16S rRNA sequencing). Material and Method: We searched PubMed, EMBASE (Ovid) and Cochrane Library for case-control studies comparing fecal gut microbiota analyzed with the GA-map® Dysbiosis Test (Oslo, Norway) in patients with IBS and HCs. Our outcomes were the difference in fecal bacterial markers and DI in patients with IBS and IBS subgroups compared to HCs. Results: The search identified 28 citations; five articles were included. Most studies evaluated fecal bacterial markers and DI in patients with diarrhea-predominant IBS (IBS-D). Results of fecal bacteria profile in IBS and IBS subgroups compared to HCs are inconsistent, however, two studies showed increased levels of Ruminococcus gnavus in IBS-D compared to HCs and results of DI indicated IBS and IBS subgroups (especially IBS-D) having higher DI compared to HCs. Conclusion: This systematic review revealed inconsistent findings in respect to differences in bacterial markers between IBS and IBS subgroups with HCs in studies using the GA-map Dysbiosis Test based on 16S rRNA sequencing. However, the test is quite novel, and few studies have used the method so far. More research comparing fecal microbiota profile differences in IBS and IBS subgroups compared to HCs utilizing the same method of analysis is needed to give us further insight into the gut bacteria profile in IBS and the clinical consequences of intestinal dysbiosis.Keywords
This publication has 45 references indexed in Scilit:
- Ruminococcus gnavus plays a pathogenic role in diarrhea-predominant irritable bowel syndrome by increasing serotonin biosynthesisCell Host & Microbe, 2022
- Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control StudiesJournal of the Academy of Nutrition and Dietetics, 2020
- The influence of ethnicity and geography on human gut microbiome compositionNature Medicine, 2018
- Actinobacteria: A relevant minority for the maintenance of gut homeostasisDigestive and Liver Disease, 2018
- Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysisDigestive and Liver Disease, 2017
- Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IVGastroenterology, 2016
- Irritable bowel syndromeNature Reviews Disease Primers, 2016
- Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin BiosynthesisCell, 2015
- Serotonin signalling in the gut—functions, dysfunctions and therapeutic targetsNature Reviews Gastroenterology & Hepatology, 2013
- Global and Deep Molecular Analysis of Microbiota Signatures in Fecal Samples From Patients With Irritable Bowel SyndromeGastroenterology, 2011